Facundo Davaro
@fdavaro
#SLUrology graduate. SUO Fellow @MoffitNews. Married to a pathologist @EPDavaro. Father of three girls!
ID: 1206368968535093248
16-12-2019 00:23:27
102 Tweet
104 Followers
169 Following
Hey Society of Urologic Oncology! Don't forget to tune in with me and Roger Li at 6p CST tomorrow night (6/12/2023) for our #ASCO2023 Recap w/ presentations from splernerMD David Braun DrBagrodia & Dr. Karen Hoffman. You don't want to miss this! Register here: suonet.org/meetings/event…
Grateful to AChangUro Heather Huelster Kyle M Rose for choosing Moffitt Urologic Oncology Fellowship for Society of Urologic Oncology fellowship training. You đź’Żepitomize compassion, skill, and excellence! Simply amazing. Will miss you! Moffitt Cancer Center OchsnerUrology Indiana University Department of Urology Duke Urology Residency Program Vanderbilt Urology Mayo Clinic Urology
UCSD is recruiting motivated SUO applicants for accredited fellowship position starting 8-2024! Come join our dynamic team Juan Javier-DesLoges, MD, MS DrBagrodia Amir Salmasi Ithaar H. Derweesh Rana McKay, MD, FASCO Tyler Seibert MD PhD DrTylerStewart
The importance of surgical margin and extent of lymphadenectomy on clinical outcomes in patients with plasmacytoid #UrothelialCarcinoma. #ExpertCommentary Dr. Bishoy M. Faltas WCM Englander Institute for Precision Medicine discusses work by Facundo Davaro et al. in Urologic Oncology > bit.ly/3rbfV4E Roger Li STARK NET COMMUNITY
Pooling together patients from MD Anderson Cancer Center Moffitt Cancer Center University of Iowa we report outcomes of IR-NMIBC patients treated with Gem-Doce vs BCG in European Urology Oncology Ian McElree Facundo Davaro Ryan L. Steinberg MD Kelly Bree Neema Navai #ColinDinney #MikeODonnell Roger Li Ashish M. Kamat, MD, MBBS Vignesh Packiam, MD
Incredible course highlighting the value of focal therapy and the importance of patient selection with invaluable insight from leaders in the field. Thank you Chris Weight Ruben Olivares MD Cleveland Clinic Urology YUO
Our study is finally online European Urology! doi.org/10.1016/j.euru…… ▶️Pre-op plasma ctDNA predicts muscle invasive #UTUC on surgical specimen ▶️ctDNA prognostic of post-surgical outcomes Amazing collaboration with Dr. Bishoy M. Faltas Andrea Necchi Joshua Meeks Predicine, Inc. Moffitt Urologic Oncology Fellowship
Collaborative effort to improve outcomes in UTUC by Moffitt Cancer Center Predicine, Inc. is officially online European Urology! Preop plasma ctDNA has 94% specificity for muscle-invasion or LN positivity at NephU ➡️ may help select optimal pts for NAC! sciencedirect.com/science/articl… Tweetorial 🔽
Many congratulations to Josh Linscott and to your đź’Żsuper mentor Roger Li. Moffitt Urologic Oncology Fellowship Moffitt Cancer Center YUO
Work led by @pbandmurthy Moffitt Urologic Oncology Fellowship 👀 at ct & utDNA🧬prior to RC Surprisingly difficult to use as staging tool, but significant increases in utDNA TF in CIS pts Philippe spiess Wade J Sexton @sgilbert1973 G. Daniel Grass MD, PhD Xuefeng Wang Joshua Meeks Andrea Necchi Liang Cheng, MD Predicine, Inc.
The only session at #AUA24 completely dedicated to highlighting the work of early-career investigators is a can't-miss event! Join us on Sunday, May 5th, and see Presenters like Allison May, MD showcase their work! Learn more and add to your schedule: bit.ly/3Q6HOod
At #AUA24, Mitch Hayes, MD, (Mitch Hayes) presents the latest research on renal cell carcinoma. #CancerResearch Amer. Urol. Assn.
This meant so much to me. Thankful to Amer. Urol. Assn. , the judges and organizers for supporting early career investigators. And my mentors Michigan Urology Saint Louis University Urology Residency Program. So much incredible research going on in the field of urology. I hope to live up to it UVA Urology!
Hard to believe Chris Guske is only an MS2! Already doing great research with Moffitt Urologic Oncology Fellowship. Really well received presentation on increased risk of progression for BCG unresponsive patients when there are delays in initiating BST. #AUA2024
Promising results with combination Oncolytic Adenovirus+Pembro in bladder cancer reported in Nature Medicine by Roger Li from Moffitt Cancer Center
